Last reviewed · How we verify

NCT06079255: IDEA

Ischemia Detection During Development of Acute Compartment Syndrome

Not yet recruiting Last updated 25 March 2025
What this trial tests

trial testing IscAlert sensor(s) in patient with risk of acute compartment syndrome in Ischemia Limb in 60 participants. Not yet recruiting.

Timeline
15 October 2025
Primary endpoint
28 February 2027
30 October 2027

Quick facts

Lead sponsorOslo University Hospital
StatusNot yet recruiting
Study typeOBSERVATIONAL
Enrollment60
Start date15 October 2025
Primary completion28 February 2027
Estimated completion30 October 2027
Sites1 location across Norway

Drugs / interventions tested

Conditions studied

Sponsor

Oslo University Hospital

Who can join

Adults 18 to 110, any sex, with Ischemia Limb or Blood Circulation Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is an open, observational, prospective, descriptive, single-centre study including 60 patients. The study is designed to investigate if IscAlert sensor system can be used for reliable and continuous tissue carbon dioxide (pCO2)- and temperature monitoring in muscular tissue in lower extremity in patients at risk of developing acute compartment syndrome.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Oslo University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06079255.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing